Have you got a current driving licence? septran medicine online Merck has been pursuing a second chance for the drug in theU.S. after the FDA rejected sugammadex in 2008 because of thepotential for allergic reactions and bleeding. Sugammadex, whichis approved in 40 other countries as Bridion, may be used in 25percent of the 30 million general anesthesia surgeries conductedeach year in the U.S. if cleared by the FDA, Whitehouse Station,New Jersey-based Merck said on a May 1 conference call.